The Icahn School of Medicine at Mount Sinai has received a $4 million grant to establish its Skin Biology and Diseases Resource-based Center (SBDRC).
The grant is a five-year P30 grant from the National Institutes of Health and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
The Mount Sinai SBDRC will be a hub for research in skin biology and skin diseases throughout the Mount Sinai Health System, New York City and the tri-state region.
“This new Center will continue our efforts at Mount Sinai to accelerate research in skin biology and diseases, and promote translation of that understanding to benefit our patients across the entire health system,” said Dr. Elena Ezhkova, professor of cell, developmental and regenerative biology and dermatology in the Black Family Stem Cell Institute at Icahn Mount Sinai. “We will also ensure a vibrant future for skin biology and diseases research by aiding the early careers and development of outside investigators and physician-scientists through training and financial support, as well as enhancing the diversity of our research community through targeted recruitment and mentoring of young scientists from all backgrounds.”
The center will use the technical innovations, high-end infrastructure and computing power available at Mount Sinai to advance and support skin research, and will embed experts in gene editing, genomics and bioinformatics within skin research labs to break down interdisciplinary communication barriers.
The SBDRC program will also provide in-person and virtual events, such as seminars and research-in-progress talks, to facilitate collaboration in cutaneous biology and diseases. The center will promote research and innovation through three resource cores: Skin Disease Modeling; Skin Genomics, Transcriptomics, and Epigenetics; and Data Analysis and Integration.
